Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -275.74% is 145% below its 5-year average of -112.76%, around the middle of its 5-year range (-395.10%–-23.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 70.32% below its 12-month average of -161.89%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -275.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-275.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-161.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-82.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-112.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-214.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-214.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-70.32%
CURRENT VS 3Y AVG
-235.20%
CURRENT VS 5Y AVG
-144.54%
CURRENT VS 10Y AVG
-28.68%
CURRENT VS 15Y AVG
-28.68%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-673.58%
vs the sector median at left
VistaGen Therapeutics, Inc.
Market Cap
$11.36M
Return on Invested Capital (ROIC)
-275.74%
TTM Avg
-161.89%
3Y Avg
-82.26%
5Y Avg
-112.76%
Market Cap
$11.25M
Return on Invested Capital (ROIC)
-204.32%
TTM Avg
-100.17%
3Y Avg
-85.05%
5Y Avg
-71.75%
Market Cap
$11.50M
Return on Invested Capital (ROIC)
-100.51%
TTM Avg
-100.10%
3Y Avg
-111.41%
5Y Avg
-95.28%
Market Cap
$11.12M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
Market Cap
$11.13M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$11.09M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
Market Cap
$11.08M
Return on Invested Capital (ROIC)
-59.42%
TTM Avg
-18.05%
3Y Avg
-54.95%
5Y Avg
-57.91%
Market Cap
$10.82M
Return on Invested Capital (ROIC)
-465.34%
TTM Avg
-276.05%
3Y Avg
-276.05%
5Y Avg
-276.05%
Market Cap
$11.93M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VistaGen Therapeutics, Inc. (VTGN) | $11.36M | -275.74% | -161.89% | -82.26% | -112.76% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.25M | -204.32% | -100.17% | -85.05% | -71.75% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.50M | -100.51% | -100.10% | -111.41% | -95.28% |
| Cerenome, Inc. (CNSY)vs › | $11.12M | -479.39% | -317.58% | -249.47% | -183.14% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.13M | -240.64% | -174.03% | -198.05% | -242.53% |
| BioVie Inc. (BIVI)vs › | $11.09M | -216.67% | -46.84% | -98.66% | -549.86% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | -59.42% | -18.05% | -54.95% | -57.91% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -465.34% | -276.05% | -276.05% | -276.05% |
| Biofrontera Inc. (BFRI)vs › | $11.93M | -32.27% | -112.80% | -113.13% | -94.20% |
| Pluri Inc. (PLUR)vs › | $10.69M | -127.37% | -96.60% | -79.17% | -74.39% |
ROIC
-275.7%
ROE
-276.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -275.74% |
| 2026-03-31 | -201.09% |
| 2025-12-31 | -134.66% |
| 2025-09-30 | -96.36% |
| 2025-06-30 | -101.61% |
| 2025-03-31 | -78.03% |
| 2024-12-31 | -63.90% |
| 2024-09-30 | -48.01% |
| 2024-06-30 | -35.55% |
| 2024-03-31 | -27.86% |
| 2023-12-31 | -26.71% |
| 2023-09-30 | -91.08% |
| 2023-06-30 | -395.10% |
| 2023-03-31 | -356.61% |
| 2022-12-31 | -246.60% |
| 2022-09-30 | -182.26% |
| 2022-06-30 | -117.64% |
| 2022-03-31 | -69.37% |
| 2021-12-31 | -44.35% |
| 2021-09-30 | -34.63% |
| 2021-06-30 | -23.10% |
| 2021-03-31 | -3013.30% |
| 2020-12-31 | -2945.49% |
| 2020-09-30 | -18095.07% |
| 2020-06-30 | -79954.56% |
| 2020-03-31 | -680.34% |
| 2019-12-31 | -943.80% |
| 2019-09-30 | -512.60% |
| 2019-06-30 | -268.79% |
| 2019-03-31 | -217.93% |
| 2018-12-31 | -408.77% |
| 2018-09-30 | -241.50% |
| 2018-06-30 | -245.98% |
| 2018-03-31 | -143.81% |
| 2017-12-31 | -97.76% |
| 2017-09-30 | -1483.74% |
| 2017-06-30 | -660.10% |
| 2017-03-31 | -427.11% |
| 2016-12-31 | -401.06% |
| 2016-09-30 | -296.49% |
| 2016-06-30 | -247.76% |
| 2010-06-30 | -507.09% |
| 2010-03-31 | -1254.65% |
| 2009-12-31 | -5842.55% |
| 2009-09-30 | -1880.99% |
| 2009-06-30 | -2051.90% |
| 2009-03-31 | -992.87% |
| 2008-12-31 | -78.50% |
